ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,122Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 1749

$5.35M Total Retail Price of All Prescriptions

Rank: 1 out of 1749

802 Patients Receiving at Least One Drug in Part D
14%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

6% of this provider’s 2,930 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$184 was the average price of a prescription from this provider, compared to $143 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
CLOZAPINE 4,590 287 10 1 11
BENZTROPINE MESYLATE 2,085 142 R 10 2 3
OLANZAPINE 2,075 343 10 3 6
QUETIAPINE FUMARATE 1,298 114 10 4 4
CYMBALTA 1,247 118 10 5 12
RISPERIDONE 1,080 215 6 1
PERPHENAZINE 934 28 10 7 44
ABILIFY 855 157 8 5
PAROXETINE HCL 779 107 9 19
VENLAFAXINE HCL ER 740 55 10 10 17
ZIPRASIDONE HCL 689 64 10 11 28
LAMOTRIGINE 665 39 12 14
DIVALPROEX SODIUM ER 620 42 13 13
TOPIRAMATE 535 26 14 29
LATUDA 513 28 10 15 35
SEROQUEL 475 43 16 24
CITALOPRAM HBR 444 41 17 10
TRAZODONE HCL 416 55 18 2
LITHIUM CARBONATE 407 44 19 20
DESMOPRESSIN ACETATE 403 0 10 20 89
INVEGA SUSTENNA 387 22 21 32
SERTRALINE HCL 383 61 22 7
DIVALPROEX SODIUM 362 38 23 15
FLUPHENAZINE HCL 362 26 10 23 36
BUPROPION HCL SR 359 35 25 22
INVEGA 324 0 10 26 45
HALOPERIDOL 315 35 27 21
FANAPT 306 35 10 28 62
MIRTAZAPINE 292 58 29 16
FLUOXETINE HCL 282 37 30 8
HYDROXYZINE PAMOATE 259 0 R 31 43
OXCARBAZEPINE 251 22 32 39
FAMOTIDINE 230 11 33 117
BUSPIRONE HCL 222 0 34 26
GEODON 198 20 10 35 55
ZOLPIDEM TARTRATE 190 11 36 9
PROPRANOLOL HCL 184 30 37 41
VENLAFAXINE HCL 181 0 38 80
AMANTADINE 172 47 39 92
ESCITALOPRAM OXALATE 167 16 40 23
LACTULOSE 158 0 41 96
NAMENDA 140 85 42 31
OLANZAPINE ODT 134 38 43 40
FLUVOXAMINE MALEATE 116 13 44 54
TRIHEXYPHENIDYL HCL 114 23 R 45 33
EXELON 95 55 46 51
OMEPRAZOLE 85 25 47 60
DONEPEZIL HCL 81 28 48 30
FLUPHENAZINE DECANOATE 76 0 49 79
BETHANECHOL CHLORIDE 76 0 49 169
NALTREXONE HCL 71 0 51 110
HYDROXYZINE HCL 71 15 R 51 69
OXYBUTYNIN CHLORIDE 68 0 53 131
GABAPENTIN 66 12 54 27
SEROQUEL XR 62 0 55 25
LEVETIRACETAM 60 13 56 91
RISPERDAL CONSTA 60 0 56 42
THIORIDAZINE HCL 57 0 R 58 78
SAPHRIS 56 0 59 56
CARBAMAZEPINE 56 0 59 46
LEXAPRO 55 0 61 38
MEGESTROL ACETATE 51 0 R 62 106
OXYBUTYNIN CHLORIDE ER 50 0 63 145
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 17, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.